Altered CXCR2 signaling in β-arrestin-2-deficient mouse models

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 5396-5402

  Su, Yingjun ^b,c   Raghuwanshi, Sandeep K ^d   Yu, Yingchun ^b,c   Nanney, Lillian B ^b   Richardson, Ricardo M ^d   Richmond, Ann ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CALCIUM ION; CHEMOKINE RECEPTOR CXCR2; DNA; GUANOSINE TRIPHOSPHATASE; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; EPITHELIZATION; EXCISION; GENOTYPE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERNALIZATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING;

EID: 26844441796     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.5396     Document Type: Article

References (51)

1. Bignold, L. P., S. D. Rogers, T. M. Siaw, and J. Bahnisch. 1991. Inhibition of chemotaxis of neutrophil leukocytes to interleukin-8 by endotoxins of various bacteria. Infect. Immun. 59: 4255-4258.
2. Goya, T., T. Morisaki, and M. Torisu. 1994. Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery 115: 145-155.
3. Wagner, J. G., and R. A. Roth. 1999. Neutrophil migration during endotoxemia. J. Leukocyte Biol. 66: 10-24.
4. Chishti, A. D., B. K. Shenton, J. A. Kirby, and S. V. Baudouin. 2004. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med. 30: 605-611.
5. Miller, A. P., W. Feng, D. Xing, N. M. Weathington, J. E. Blalock, Y. F. Chen, and S. Oparil. 2004. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 110: 1664-1669.
6. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340: 115-126.
7. Libby, P., P. M. Ridker, and A. Maseri. 2002. Inflammation and atherosclerosis. Circulation 105: 1135-1143.
8. Wetzler, C., H. Kampfer, B. Stallmeyer, J. Pfeilschifter, and S. Frank. 2000. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J. Invest. Dermatol. 115: 245-253.
9. Ajuebor, M. N., J. Zagorski, S. L. Kunkel, R. M. Strieter, and C. M. Hogaboam. 2004. Contrasting roles for CXCR2 during experimental colitis. Exp. Mol. Pathol. 76: 1-8.
10. Keshavarzian, A., R. D. Fusunyan, M. Jacyno, D. Winship, R. P. MacDermott, and I. R. Sanderson. 1999. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am. J. Gastroenterol. 94: 704-712.
11. Sue, R. D., J. A. Belperio, M. D. Burdick, L. A. Murray, Y. Y. Xue, M. C. Dy, J. J. Kwon, M. P. Keane, and R. M. Strieter. 2004. CXCR2 is critical to hyperoxia-induced lung injury. J. Immunol. 172: 3860-3868.
12. Belperio, J. A., M. P. Keane, M. D. Burdick, V. Londhe, Y. Y. Xue, K. Li, R. J. Phillips, and R. M. Strieter. 2002. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110: 1703-1716.
13. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
14. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568.
15. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176.
16. Arai, H., and I. F. Charo. 1996. Differential regulation of G-protein-mediated signaling by chemokine receptors. J. Biol. Chem. 271: 21814-21819.
17. Smith, C. D., C. C. Cox, and R. Snyderman. 1986. Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein. Science 232: 97-100.
18. Luttrell, L. M., and R. J. Lefkowitz. 2002. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115: 455-465.
19. Barlic, J., J. D. Andrews, A. A. Kelvin, S. E. Bosinger, M. E. DeVries, L. Xu, T. Dobransky, R. D. Feldman, S. S. Ferguson, and D. J. Kelvin. 2000. Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCRI. Nat. Immunol. 1: 227-233.
20. Richardson, R. M., R. J. Marjoram, L. S. Barak, and R. Snyderman. 2003. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J. Immunol. 170: 2904-2911.
21. Yang, W., D. Wang, and A. Richmond. 1999. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction. J. Biol. Chem. 274: 11328-11333.
22. Fan, G. H., L. A. Lapierre, J. R. Goldenring, J. Sai, and A. Richmond. 2004. Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis. Mol. Biol. Cell 15: 2456-2469.
23. Fan, G. H., W. Yang, J. Sai, and A. Richmond. 2001. Phosphorylation- independent association of CXCR2 with the protein phosphatase 2A core enzyme. J. Biol. Chem. 276: 16960-16968.
24. Fan, G. H., W. Yang, X. J. Wang, Q. Qian, and A. Richmond. 2001. Identification of a motif in the carboxyl terminus of CXCR2 that is involved in adaptin 2 binding and receptor internalization. Biochemistry 40: 791-800.
25. Fan, G. H., W. Yang, J. Sai, and A. Richmond. 2002. Hsc/Hsp70 interacting protein (hip) associates with CXCR2 and regulates the receptor signaling and trafficking. J. Biol. Chem. 277: 6590-6597.
26. Bohn, L. M., R. J. Lefkowitz, R. R. Gainetdinov, K. Peppel, M. G. Caron, and F. T. Lin. 1999. Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 286: 2495-2498.
27. Bohn, L. M., R. R. Gainetdinov, F. T. Lin, R. J. Lefkowitz, and M. G. Caron. 2000. Mu-opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature 408: 720-723.
28. Fong, A. M., R. T. Premont, R. M. Richardson, Y. R. Yu, R. J. Lefkowitz, and D. D. Patel. 2002. Defective lymphocyte chemotaxis in β-arrestin 2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. USA 99: 7478-7483.
29. Edwards, J. C., A. D. Sedgwick, and D. A. Willoughby. 1981. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134: 147-156.
30. Sin, Y. M., A. D. Sedgwick, E. P. Chea, and D. A. Willoughby. 1986. Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse. Ann. Rheum. Dis. 45: 873-877.
31. Clish, C. B., J. A. O'Brien, K. Gronert, G. L. Stahl, N. A. Petasis, and C. N. Serhan. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96: 8247-8252.
32. Tomhave, E. D., R. M. Richardson, J. R. Didsbury, L. Menard, R. Snyderman, and H. Ali. 1994. Cross-desensitization of receptors for peptide chemoattractants: characterization of a new form of leukocyte regulation. J. Immunol. 153: 3267-3275.
33. Chuntharapai, A., and K. J. Kim. 1995. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J. Immunol. 155: 2587-2594.
34. Haribabu, B., R. M. Richardson, I. Fisher, S. Sozzani, S. C. Peiper, R. Horuk, H. Ali, and R. Snyderman. 1997. Regulation of human chemokine receptors CXCR4: role of phosphorylation in desensitization and internalization. J. Biol. Chem. 272: 28726-28731.
35. Meller, N., Y. Elitzur, and N. Isakov. 1999. Protein kinase C-θ (PKCθ) distribution analysis in hematopoietic cells: proliferating T cells exhibit high proportions of PKCθ in the particulate fraction. Cell. Immunol. 193: 185-193.
36. Devalaraja, R. M., L. B. Nanney, J. Du, Q. Qian, Y. Yu, M. N. Devalaraja, and A. Richmond. 2000. Delayed wound healing in CXCR2 knockout mice. J. Invest Dermatol. 115: 234-244.
37. Nanney, L. B. 1990. Epidermal and dermal effects of epidermal growth factor during wound repair. J. Invest. Dermatol 94: 624-629.
38. Thorey, I. S., B. Hinz, A. Hoeflich, S. Kaesler, P. Bugnon, M. Elmlinger, and R. Wanke. 2004. Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis and myofibroblast differentiation. J. Biol. Chem. 279: 26674-26684.
39. Milatovic, S., L. B. Nanney, Y. Yu, J. R. White, and A. Richmond. 2003. Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair Regen. 11: 213-219.
40. Tohgo, A., K. L. Pierce, E. W. Choy, R. J. Lefkowitz, and L. M. Luttrell. 2002. β-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277: 9429-9436.
41. Tohgo, A., E. W. Choy, D. Gesty-Palmer, K. L. Pierce, S. Laporte, R. H. Oakley, M. G. Caron, R. J. Lefkowitz, and L. M. Luttrell. 2003. The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem. 278: 6258-6267.
42. Sun, Y., Z. Cheng, L. Ma, and G. Pei. 2002. β-Arrestin 2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277: 49212-49219.
43. Richardson, R. M., B. C. Pridgen, B. Haribabu, and R. Snyderman. 2000. Regulation of the human chemokine receptor CCR1: cross-regulation by CXCR1 and CXCR2. J. Biol. Chem. 275: 9201-9208.
44. Zhao, M., A. Wimmer, K. Trieu, R. G. Discipio, and I. U. Schraufstatter. 2004. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2. J. Biol. Chem. 279: 49259-49267.
45. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57: 827-872.
46. Smith, M. L., T. S. Olson, and K. Ley. 2004. CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo. J. Exp. Med. 200: 935-939.
47. Pierce, K. L., and R. J. Lefkowitz. 2001. Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors. Nat. Rev. Neurosci. 2: 727-733.
48. 2-adrenergic receptor. Nature 383: 447-450.
49. 2-adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci. USA 96: 3712-3717.
50. Oakley, R. H., S. A. Laporte, J. A. Holt, M. G. Caron, and L. S. Barak. 2000. Differential affinities of visual arrestin, β arrestin 1, and β arrestin 2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275: 17201-17210.
51. Conner, D. A., M. A. Mathier, R. M. Mortensen, M. Christe, S. F. Vatner, C. E. Seidman, and J. G. Seidman. 1997. β-Arrestin 1 knockout mice appear normal but demonstrate altered cardiac responses to β-adrenergic stimulation. Circ. Res. 81: 1021-1026.